<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>127(8)</volume><submitter>Bicchetti M</submitter><funding>Università degli Studi di Roma La Sapienza</funding><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To determine the clinical, pathological, and radiological features, including the Vesical Imaging-Reporting and Data System (VI-RADS) score, independently correlating with muscle-invasive bladder cancer (BCa), in a multicentric national setting.&lt;h4>Method and materials&lt;/h4>Patients with BCa suspicion were offered magnetic resonance imaging (MRI) before trans-urethral resection of bladder tumor (TURBT). According to VI-RADS, a cutoff of ≥ 3 or ≥ 4 was assumed to define muscle-invasive bladder cancer (MIBC). Trans-urethral resection of the tumor (TURBT) and/or cystectomy reports were compared with preoperative VI-RADS scores to assess accuracy of MRI for discriminating between non-muscle-invasive versus MIBC. Performance was assessed by ROC curve analysis. Two univariable and</pubmed_abstract><journal>La Radiologia medica</journal><pagination>881-890</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9349064</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.</pubmed_title><pmcid>PMC9349064</pmcid><pubmed_authors>Schiavina R</pubmed_authors><pubmed_authors>Panebianco V</pubmed_authors><pubmed_authors>Briganti A</pubmed_authors><pubmed_authors>Brunocilla E</pubmed_authors><pubmed_authors>De Cobelli F</pubmed_authors><pubmed_authors>Flammia S</pubmed_authors><pubmed_authors>Catalano C</pubmed_authors><pubmed_authors>Girometti R</pubmed_authors><pubmed_authors>Cardone G</pubmed_authors><pubmed_authors>Bicchetti M</pubmed_authors><pubmed_authors>Simone G</pubmed_authors><pubmed_authors>Pecoraro M</pubmed_authors><pubmed_authors>Leonardo C</pubmed_authors><pubmed_authors>Giannarini G</pubmed_authors><pubmed_authors>Gaudiano C</pubmed_authors><pubmed_authors>Del Giudice F</pubmed_authors></additional><is_claimable>false</is_claimable><name>A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.</name><description>&lt;h4>Purpose&lt;/h4>To determine the clinical, pathological, and radiological features, including the Vesical Imaging-Reporting and Data System (VI-RADS) score, independently correlating with muscle-invasive bladder cancer (BCa), in a multicentric national setting.&lt;h4>Method and materials&lt;/h4>Patients with BCa suspicion were offered magnetic resonance imaging (MRI) before trans-urethral resection of bladder tumor (TURBT). According to VI-RADS, a cutoff of ≥ 3 or ≥ 4 was assumed to define muscle-invasive bladder cancer (MIBC). Trans-urethral resection of the tumor (TURBT) and/or cystectomy reports were compared with preoperative VI-RADS scores to assess accuracy of MRI for discriminating between non-muscle-invasive versus MIBC. Performance was assessed by ROC curve analysis. Two univariable and</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T22:36:35.864Z</modification><creation>2025-04-04T22:36:35.864Z</creation></dates><accession>S-EPMC9349064</accession><cross_references><pubmed>35763251</pubmed><doi>10.1007/s11547-022-01513-5</doi></cross_references></HashMap>